3-41234217-C-T
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_001904.4(CTNNB1):c.1603C>T(p.Arg535*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_001904.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTNNB1 | NM_001904.4 | c.1603C>T | p.Arg535* | stop_gained | Exon 10 of 15 | ENST00000349496.11 | NP_001895.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Severe intellectual disability-progressive spastic diplegia syndrome Pathogenic:7
- -
Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss of function is a known mechanism of disease in this gene and is associated with neurodevelopmental disorder with spastic diplegia and visual defects (MIM#615075), and exudative vitreoretinopathy 7 (MIM#617572). However, somatic variants with a gain of function mechanism have been reported to cause cancer (OMIM). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (ClinVar). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported in two de novo individuals with intellectual disability (PMID: 27915094). It has also been reported multiple times as pathogenic in ClinVar. (SP) 1203 - This variant has been shown to be de novo in the proband (parental status confirmed) (by trio analysis). (SP) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign -
This variant meets our criteria to be classified as pathogenic based upon segregation studies, absence from controls, and in-silico evaluation of pathogenicity. -
Submission from Simons Searchlight facilitated by GenomeConnect. Variant interpreted by the Simons Searchlight team most recently on 2017-02-06 and interpreted as Pathogenic. Variant was initially reported on 2014-10-27 by GTR ID of laboratory name 26957. The reporting laboratory might also submit to ClinVar. -
- -
Variant summary: CTNNB1 c.1603C>T (p.Arg535X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. The variant was absent in 251432 control chromosomes. c.1603C>T has been reported in the literature in individuals affected with Intellectual Disability (example: Kayumi_2022). The following publication has been ascertained in the context of this evaluation (PMID: 36083290). ClinVar contains an entry for this variant (Variation ID: 265085). Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
not provided Pathogenic:3
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 36419413, 36943625, 33057194, 35982159, 25533962, 27915094, 31309540, 28135719, 30952489, 28191890, 26350204, 33425807, 31031587, 32334381, 31785789, 37009120, 36293418, 36083290) -
CTNNB1: PS2:Very Strong, PVS1, PM2, PS4:Moderate -
This sequence change creates a premature translational stop signal (p.Arg535*) in the CTNNB1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CTNNB1 are known to be pathogenic (PMID: 23033978, 24614104, 25326669, 26350204, 28575650). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with CTNNB1-related conditions (PMID: 26350204, 27915094). ClinVar contains an entry for this variant (Variation ID: 265085). For these reasons, this variant has been classified as Pathogenic. -
Intellectual disability Pathogenic:1
- -
Abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity Pathogenic:1
- -
Exudative vitreoretinopathy 7 Pathogenic:1
This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868]. This variant has been previously reported as de novo in at least two patients with syndromic developmental disorder [PMID 26350204, 27915094] -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at